1. Home
  2. POWI vs HRMY Comparison

POWI vs HRMY Comparison

Compare POWI & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Power Integrations Inc.

POWI

Power Integrations Inc.

HOLD

Current Price

$36.22

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$39.60

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWI
HRMY
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
POWI
HRMY
Price
$36.22
$39.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$60.00
$51.33
AVG Volume (30 Days)
848.1K
780.1K
Earning Date
11-05-2025
11-04-2025
Dividend Yield
2.36%
N/A
EPS Growth
N/A
50.44
EPS
0.32
3.17
Revenue
$445,550,000.00
$825,944,000.00
Revenue This Year
$7.93
$20.68
Revenue Next Year
$7.60
$15.93
P/E Ratio
$114.85
$12.57
Revenue Growth
10.49
21.13
52 Week Low
$30.86
$25.52
52 Week High
$68.20
$40.93

Technical Indicators

Market Signals
Indicator
POWI
HRMY
Relative Strength Index (RSI) 50.99 84.53
Support Level $32.81 $32.77
Resistance Level $33.93 $36.20
Average True Range (ATR) 1.32 1.21
MACD 0.70 0.36
Stochastic Oscillator 84.46 96.26

Price Performance

Historical Comparison
POWI
HRMY

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: